# Federico II University

Organization · id `cardio:org-federico-ii-university` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Federico+II+University>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Federico II University
- Sponsor class: OTHER

## Connected pages

- Sponsors: MGuard Stent in ST-elevation Myocardial Infarction (`cardio:ct-nct01124942`)
- Sponsors: Role of a Combination of Nutraceuticals (Ritmonutra) on Benign Supraventricular and Ventricular Arrhythmias (`cardio:ct-nct01647984`)
- Sponsors: Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment (POPular Genetics) (`cardio:ct-nct01761786`)
- Sponsors: Endovenous Versus Liposomal Iron in CKD (`cardio:ct-nct01864161`)
- Sponsors: Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD (`cardio:ct-nct02798913`)
- Sponsors: Effects of Beta-blockade on Platelet Aggregation in Acute Coronary Syndrome (`cardio:ct-nct02809820`)
- Sponsors: Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES (`cardio:ct-nct04135989`)
- Sponsors: Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH) (`cardio:ct-nct06922994`)
- Sponsors: Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study (`cardio:ct-nct07380919`)

## Provenance

Content hash: 94e6c63ed9ddef0156289dc8e4e1bdd67e0b5539e1f6c066b5cbb1b0d141b698
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
